News

New survey results from the Pistoia Alliance, the Quantum Economic Development Consortium (QED-C) and QuPharm show almost one third (31 percent) of life science organisations polled are set to begin quantum computing evaluation this year. A further 39 percent...

Byondis B.V. announced that Quantum Leap Healthcare Collaborative selected the company’s investigational antibody-drug conjugate (ADC) SYD985 (trastuzumab duocarmazine) for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer. This...

Air freight experts at Tim Consult have launched the special Market Intelligence Initiative “MII Pharma Air Cargo”, aimed at providing pharmaceutical industry specialists with a trusty guide through the labyrinthine world of temperature–controlled global air freight markets. With its regular...

Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19. Scientists in academic centres and companies around the world desperately search for novel therapeutics and vaccines to treat and prevent COVID-19. However, with lockdowns and limited access to...

Pfizer Inc. and BioNTech SE announced that two of the companies’ four investigational vaccine candidates from their BNT162 mRNA-based vaccine program (BNT162b1 and BNT162b2) being developed to help protect against SARS-CoV-2 (the virus that causes COVID-19), received Fast Track...

IDIFARMA, a Spanish contract development and manufacturing organisation (CDMO) specialising in niche and highly potent products, has announced the appointment of Alfredo Gómez as its head of site. In his new role Alfredo Gómez will be responsible for ensuring the...

Pharma major Cipla said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowest globally and is looking to supply over 80,000 vials within the first month. The company, however, did...